Circulating CD4+ T-cell number decreases in rheumatoid patients with clinical response to rituximab

Rheumatol Int. 2015 Sep;35(9):1571-3. doi: 10.1007/s00296-015-3295-0. Epub 2015 May 30.
No abstract available

MeSH terms

  • Adult
  • Aged
  • Antirheumatic Agents / pharmacology
  • Antirheumatic Agents / therapeutic use*
  • Arthritis, Rheumatoid / blood*
  • Arthritis, Rheumatoid / drug therapy*
  • CD4-Positive T-Lymphocytes / drug effects*
  • Female
  • Humans
  • Lymphocyte Count
  • Male
  • Middle Aged
  • Retrospective Studies
  • Rituximab / pharmacology
  • Rituximab / therapeutic use*
  • Treatment Outcome

Substances

  • Antirheumatic Agents
  • Rituximab